Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 1 of 1
Full-Text Articles in Business
Tmi : An Examination Of Excess Returns Surrounding Phase Iii Fda Approvals, Luke Chiotelis
Tmi : An Examination Of Excess Returns Surrounding Phase Iii Fda Approvals, Luke Chiotelis
Honors Theses
Over the past three decades, the Biotechnology and Pharmaceutical industry has had the largest growth rate of any sector in the U.S. economy. Currently, the largest 10 companies have a market cap of over 700 billion dollars. In the past 20 years, Biotech has outperformed the Standard and Poor’s 500 index earning superior returns for those willing to invest in this risky, high growth industry (Bloomberg L.P.). This upward trend is expected to continue as both institutional and private investment in biotech continues to soar.
A better understanding of the FDA approval process and the way a company’s stock price …